Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

by Osnat Itzhaki Ben Zadok, MD, MS, Ben Ben-Avraham, MD, Anju Nohria, MD, Katia Orvin, MD, Mithal Nassar, MD, Zaza Iakobishvili, MD, PhD, Victoria Neiman, MD, Hadar Goldvaser, MD, Ran Kornowski, MD, Tuvia Ben Gal, MD
Published 2019-09-01

Efficacy of Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer 
with Rare Mutation

by Teng LI, Junling LI
Published 2021-01-01

Immune checkpoint inhibitor-related acral vasculitis

by Thibault Comont, Vincent Sibaud, Loïc Mourey, Pierre Cougoul, Odile Beyne-Rauzy
Published 2018-11-01

Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update

by Sonja Vukadin, Farah Khaznadar, Tomislav Kizivat, Aleksandar Vcev, Martina Smolic
Published 2021-07-01

HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors – a case report

by Johannes Sumer, Frederike Waldeck, Nadja Fischer, Christina Appenzeller, Markus Koster, Martin Früh, Werner C. Albrich
Published 2021-01-01

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy

by M. Xipell, I. Victoria, V. Hoffmann, J. Villarreal, A. García-Herrera, O. Reig, L. Rodas, M. Blasco, E. Poch, B. Mellado, L. F. Quintana
Published 2018-07-01

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors

by Elizabeth Dudnik, Elizabeth Dudnik, Jair Bar, Jair Bar, Assaf Moore, Teodor Gottfried, Mor Moskovitz, Julia Dudnik, Tzippy Shochat, Aaron M. Allen, Aaron M. Allen, Alona Zer, Alona Zer, Ofer Rotem, Nir Peled, Nir Peled, Damien Urban, Damien Urban
Published 2021-03-01

Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors

by Liu W, Liu Y, Ma F, Sun B, Wang Y, Luo J, Liu M, Luo Z
Published 2021-01-01

Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review

by El Sabbagh R, Azar NS, Eid AA, Azar ST
Published 2020-11-01

Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies

by Julie Belliere, Julien Mazieres, Nicolas Meyer, Leila Chebane, Fabien Despas
Published 2021-06-01

Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma

by Rosalba Buquicchio, Valentina Mastrandrea, Sabino Strippoli, Davide Quaresmini, Michele Guida, Raffaele Filotico
Published 2021-08-01

Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?

by Jonathan Khalifa, Jonathan Khalifa, Julien Mazieres, Julien Mazieres, Carlos Gomez-Roca, Carlos Gomez-Roca, Maha Ayyoub, Maha Ayyoub, Elizabeth Cohen-Jonathan Moyal, Elizabeth Cohen-Jonathan Moyal, Elizabeth Cohen-Jonathan Moyal
Published 2021-04-01

Management of Immune Checkpoint Inhibitor Toxicities

by Durrechou Q, Domblides C, Sionneau B, Lefort F, Quivy A, Ravaud A, Gross-Goupil M, Daste A
Published 2020-09-01

Immunotherapy improves efficiency of conversion surgery for metastatic gastric cancer: A case report

by Che-Pin Lin, Yung-Chuan Sung, Jia-Uei Wong
Published 2020-10-01

Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports

by Hsiu-Jung Tung, Chun-Chieh Wang, Feng-Yuan Liu, Chyong-Huey Lai
Published 2021-09-01

Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials

by Daniele Marinelli, Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, Teresa Gamucci, Clara Natoli, Antonino Grassadonia, Nicola Tinari, Silverio Tomao, Isabella Sperduti, Giuseppe Sanguineti, Andrea Botticelli, Agnese Fabbri, Claudio Botti, Gennaro Ciliberto, Maddalena Barba, Patrizia Vici
Published 2020-09-01

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research

by Yoshiya Hosokawa, Toshiaki Hanafusa, Akihisa Imagawa
Published 2019-09-01

Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events

by Yoshiyuki Nakamura
Published 2019-05-01

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

by Asim Amin, Asim Amin, Hans Hammers
Published 2019-01-01

Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells

by Chihiro Tanaka, Takuro Kobori, Mayuka Tameishi, Yoko Urashima, Takuya Ito, Tokio Obata
Published 2021-09-01